Lexaria Bioscience Corp. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Related Party Transactions

Related Party Transactions

9 Months Ended

May 31, 2019

15. Related Party Transactions

For the period ended May 31, 2019, the Company paid/accrued the following:

	Contract		Non-Cash		May 31, 2019 $		Contract		Non-Cash		May 31, 2018 $
Management, consulting and accounting services:
C.A.B Financial Services Ltd. (“CAB”)⁽¹⁾⁽²⁾		157,255		-		157,255		108,000		1,002,705		1,110,705
M&E Services Ltd. (“M&E”)⁽¹⁾		83,110		-		83,110		58,140		501,101		559,241
Docherty Management Limited (“Docherty Management”)⁽¹⁾		139,021		-		139,021		106,067		968,329		1,074,396
Company controlled by a director Consulting		-		-		-		12,000		57,395		69,395
Board of Director Fees		18,553		225,436		243,989		-		57,395		57,395
		397,939		225,436		623,375		284,207		2,586,925		2,871,132

⁽¹⁾CAB is owned by the CEO of the Company, M&E is owned by the CFO of the Company, and Docherty Management is owned by the President of the Company.

Due to related parties:

As at May 31, 2019, $20,995 (August 31, 2018 - $7,855) was payable to related parties, which are recorded at the exchange amount established and agreed to between the related parties.